TrialJournal for immunotherapy of cancer2020

Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up.

Joost H van den Berg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.